WuXi Biologics passes GMP inspection by Japan PMDA for its drug substance facilities in Wuxi city: Wuxi, China Friday, February 28, 2025, 15:00 Hrs [IST] WuXi Biologics (WuXi Bio) ...
GlobalData on MSN7h
GE HealthCare announces Will Song as new president and CEO in ChinaGE HealthCare has announced a leadership transition for its China operations, with Will Song to succeed Yihao Zhang as new ...
Hang Lung Announces Official Name of Xi Zhe Wuxi, Curio Collection by Hilton at Center 66, Set to Open in Q4 2025 data-link= ...
The eastern Chinese economic powerhouse of Jiangsu Province has made significant strides in the burgeoning low-altitude ...
Qatar, a major liquefied natural gas exporter and financial hub, is also promoting itself as a tourism destination ...
Yihao Zhang, GE HealthCare’s president and CEO for China, plans to retire, effective July 1. The company picked Will Song, a ...
As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...
Wuxi BioHermes Bio & Medical Technology Co Ltd, a company specializing in the production of diabetes in vitro diagnostic products in Wuxi, Jiangsu, has allocated more resources to expand its presence ...
KPMG: Government reserves remain robust, advocates for expanded asset management and innovation industries to boost economic ...
With difficulties in sales, the pressure gradually shifted upstream to the CPL sector. Chip manufacturers generally started to slow down their CPL purchasing, either postponing or reducing. From an ...
ET Net News Agency, 28 February 2025] IMMUNEONCO-B (01541) fell 10.2% to HK$5.39, dipping below the 20-D SMA of HK$5.524. It hits an intra-day low of HK$5.39, and an intra-day hi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback